We focus a lot on the “Brain Fog” phenomenon, and seek to bring you the best information available today. Here is a scholarly article, peer reviewed and published, concerning citicoline and the brain.

Citicoline (Cognizin) in the treatment of cognitive impairment

Mario Fioravanti1 and Ann E Buckley2

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695184/

“Pharmacological treatment of cerebrovascular disorders was introduced at the beginning of the 20th Century. Since then, a multitude of studies have focused on the development of a consensus for a well defined taxonomy of these disorders and on the identification of specific patterns of cognitive deficits associated with them, but with no clear consensus. Nevertheless, citicoline has proved to be a valid treatment in patients with a cerebrovascular pathogenesis for memory disorders.”

“As a drug, citicoline has been proposed for use in traumatic brain injures, stroke, vascular dementia, Parkinson’s disease, and brain aging (Blount et al 2002) where it has the function of stabilizer of cell membranes and reduces the presence of free radicals (Zweifler 2002). In particular, there is some evidence of a stimulating role of citicoline for the release of dopamine neurotransmitters in the brain (Fonlupt et al 1985).”

“Finally, the tolerability of citicoline has never constituted a problem whatever the modality of administration or the dosage. Despite these difficulties and elements of confusion between different clinical studies performed at different periods of time, citicoline has emerged as a valid treatment for patients with chronic cerebrovascular disorders or with memory problems.”

For more information on citicoline, visit our product page at https://bodytech.blog/product/clarity/